Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis
Artificial Neural Network as Diagnostic Tools For Rifampicin-Resistant Tuberculosis In Indonesia: A Predictive Model Study and Economic Evaluation
Sponsor: Chulalongkorn University
Listed as NCT04208789, this observational or N/A phase trial focuses on MDR Tuberculosis and Resistance to Tuberculostatic Drugs and remains completed. Sponsored by Chulalongkorn University, it has been updated 7 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 2 earlier versions
-
Jul 2020 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2020 — Jul 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Chulalongkorn University
- Hasanuddin University
For direct contact, visit the study record on ClinicalTrials.gov .